Market Research Logo

High Potency APIs /HPAPI Market by Type (Innovative, Generic), Synthesis (Synthetic, Biotech, moAB, Vaccines, Recombinant Proteins), Manufacturer (Captive and Merchant), Therapy (Oncology, Glaucoma, Hormonal Imbalance) - Global Forecasts to 2023

High Potency APIs /HPAPI Market by Type (Innovative, Generic), Synthesis (Synthetic, Biotech, moAB, Vaccines, Recombinant Proteins), Manufacturer (Captive and Merchant), Therapy (Oncology, Glaucoma, Hormonal Imbalance) - Global Forecasts to 2023

“The global HPAPIs market projected to grow at a CAGR of 8.7%”
The global HPAPIs market is expected to reach USD 26.84 billion by 2023 from USD 17.72 billion in 2018, at a CAGR 8.7%. The growth in this market is driven by factors such as increasing demand for oncology drugs, growing demand for antibody-drug conjugates, increasing focus of leading pharmaceutical companies on HPAPIs, advancements in HPAPI manufacturing technologies, and growing focus on precision medicine. On the other hand, the requirement of large investments, discrepancies in HPAPI banding systems, uncertainties associated with products, and the high risk of cross-contamination are expected to limit market growth in the coming years. The need for appropriate process designs and the constant evolution of industry standards and technologies are also expected to challenge market growth to a certain extent.

“The generic HPAPIs segment is expected to grow at the highest CAGR during the forecast period”
Based on type, the HPAPIs market is segmented into innovative and generic APIs. The generic HPAPIs segment is expected to register the highest growth rate during the forecast period. The impending patent cliff, increasing healthcare costs, and government initiatives to encourage the adoption of generics are the major factors driving the growth of this market segment.

“The captive manufacturers segment is expected to dominate the market in 2018”
On the basis of type of manufacturer, the HPAPIs market is segmented into captive HPAPI and merchant HPAPI manufacturers. In 2018, the captive HPAPI manufacturers segment is expected to account for the largest share of the market. The large share of this segment is attributed to the preference of innovative companies to maintain in-house manufacturing facilities for economic benefits.

“Asia to witness the highest growth during the forecast period”
In 2018, North America is expected to account for the largest share of the market followed by Europe. However, Asia is expected to grow at the highest CAGR of 11.8% during the forecast period. Factors such as growth in geriatric population, high prevalence of chronic and lifestyle diseases, increase in disposable income, prevalence of lifestyle- and age-related diseases, government efforts to reform healthcare and encourage the adoption of generics, and growing market for merchant manufacturers in this region owing to the low labor and manufacturing costs are driving the growth of the HPAPIs market in Asia.

The primary interviews conducted for this report can be categorized as follows:
By Company Type: Tier 1 - 31%; Tier 2 - 49%; Tier 3 - 20%
By Designation: C-level- 28%; D-level- 19%; Others- 53%
By Region: North America-31%; Europe-33%; Asia Pacific-19%; Rest of the World-17%

List of companies profiled in the report
Pfizer (US)
Novartis International AG (Switzerland)
Sanofi (France)
F. Hoffmann-La Roche (Switzerland)
Bristol-Myers Squibb (US)
Boehringer Ingelheim (Germany)
Teva Pharmaceutical Industries Ltd. (Israel)
Eli Lilly and Company (US)
Merck (US)
AbbVie (US)
Mylan (US)
Bayer (Germany)

Research Coverage:
The report provides an overview of the HPAPIs market. It aims at estimating the market size and future growth potential of this market across different segments such type, type of manufacturer, type of synthesis, therapeutic application, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market by providing them with the closest approximations of revenues for the overall HPAPIs market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies make suitable go-to-market strategies. The report also will also help stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • STUDY SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • MARKET STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • SECONDARY DATA
      • KEY DATA FROM SECONDARY SOURCES
    • PRIMARY DATA
      • KEY DATA FROM PRIMARIES
      • INSIGHTS FROM INDUSTRY EXPERTS
    • MARKET SIZE ESTIMATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS: MARKET OVERVIEW
    • HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018 VS. 2023 (USD BILLION)
    • HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018 VS. 2023 (USD BILLION)
    • HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC AREA (2018–2023)
    • GEOGRAPHICAL SNAPSHOT OF THE HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
        • Table PIPELINE OF ONCOLOGY DRUGS (2018)
        • Table THERAPEUTIC MONOCLONAL ANTIBODIES APPROVED BY THE FDA IN 2016
      • RESTRAINTS
      • OPPORTUNITIES
      • CHALLENGES
  • HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS CLASSIFICATION AND OVERVIEW
    • INTRODUCTION
    • HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS CLASSIFICATION AS PER SAFEBRIDGE CONSULTANTS
  • HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE
    • INTRODUCTION
      • Table HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
    • INNOVATIVE HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS
      • Table INNOVATIVE HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: INNOVATIVE HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
      • Table EUROPE: INNOVATIVE HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
      • Table ASIA: INNOVATIVE HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
    • GENERIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS
      • Table GENERIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: GENERIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
      • Table EUROPE: GENERIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
      • Table ASIA: GENERIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
  • HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS
    • INTRODUCTION
      • Table HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2016- 2023 (USD MILLION)
    • SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS
      • Table SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2016- 2023 (USD MILLION)
      • Table NORTH AMERICA: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2016- 2023 (USD MILLION)
      • Table EUROPE: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2016- 2023 (USD MILLION)
      • Table ASIA: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2016- 2023 (USD MILLION)
      • SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE
        • Table SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
        • Table INNOVATIVE SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2016- 2023 (USD MILLION)
        • Table NORTH AMERICA: INNOVATIVE SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2016- 2023 (USD MILLION)
        • Table EUROPE: INNOVATIVE SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2016- 2023 (USD MILLION)
        • Table ASIA: INNOVATIVE SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2016- 2023 (USD MILLION)
        • Table GENERIC SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2016- 2023 (USD MILLION)
        • Table NORTH AMERICA: GENERIC SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2016- 2023 (USD MILLION)
        • Table EUROPE: GENERIC SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2016- 2023 (USD MILLION)
        • Table ASIA: GENERIC SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2016- 2023 (USD MILLION)
    • BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS
      • Table BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2016- 2023 (USD MILLION)
      • Table NORTH AMERICA: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2016- 2023 (USD MILLION)
      • Table EUROPE: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2016- 2023 (USD MILLION)
      • Table ASIA: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2016- 2023 (USD MILLION)
      • BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE
        • Table BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016- 2023 (USD MILLION)
        • Table INNOVATIVE BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2016- 2023 (USD MILLION)
        • Table NORTH AMERICA: INNOVATIVE BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2016- 2023 (USD MILLION)
        • Table EUROPE: INNOVATIVE BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2016- 2023 (USD MILLION)
        • Table ASIA: INNOVATIVE BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2016- 2023 (USD MILLION)
        • Table BIOSIMILARS MARKET, BY REGION, 2016- 2023 (USD MILLION)
        • Table NORTH AMERICA: BIOSIMILARS MARKET, BY COUNTRY, 2016- 2023 (USD MILLION)
        • Table EUROPE: BIOSIMILARS MARKET, BY COUNTRY, 2016- 2023 (USD MILLION)
        • Table ASIA: BIOSIMILARS INGREDIENTS MARKET, BY COUNTRY, 2016- 2023 (USD MILLION)
      • BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT
        • Table BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2016- 2023 (USD MILLION)
        • Table MONOCLONAL ANTIBODIES MARKET, BY REGION, 2016- 2023 (USD MILLION)
        • Table VACCINES MARKET, BY REGION, 2016- 2023 (USD MILLION)
        • Table RECOMBINANT PROTEINS MARKET, BY REGION, 2016- 2023 (USD MILLION)
  • HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER
    • INTRODUCTION
      • Table HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2016–2023 (USD MILLION)
    • CAPTIVE HPAPI MANUFACTURERS
      • Table CAPTIVE HPAPI MANUFACTURERS MARKET, BY REGION, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: CAPTIVE HPAPI MANUFACTURERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
      • Table EUROPE: CAPTIVE HPAPI MANUFACTURERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
      • Table ASIA: CAPTIVE HPAPI MANUFACTURERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
    • MERCHANT HPAPI MANUFACTURERS
      • Table MERCHANT HPAPI MANUFACTURERS MARKET, BY REGION, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: MERCHANT HPAPI MANUFACTURERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
      • Table EUROPE: MERCHANT HPAPI MANUFACTURERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
      • Table ASIA: MERCHANT HPAPI MANUFACTURERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
      • MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE
        • Table GLOBAL MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE, 2016-2023, (USD MILLION)
        • Table INNOVATIVE MERCHANT HPAPI MANUFACTURERS MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table NORTH AMERICA: INNOVATIVE MERCHANT HPAPI MANUFACTURERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table EUROPE: INNOVATIVE MERCHANT HPAPI MANUFACTURERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table ASIA: INNOVATIVE MERCHANT HPAPI MANUFACTURERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table GENERIC MERCHANT HPAPI MANUFACTURERS MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table NORTH AMERICA: GENERIC MERCHANT HPAPI MANUFACTURERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table EUROPE: GENERIC MERCHANT HPAPI MANUFACTURERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table ASIA: GENERIC MERCHANT HPAPI MANUFACTURERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
      • MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS
        • Table MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2016-2023, (USD MILLION)
        • Table MERCHANT SYNTHETIC HPAPI MANUFACTURERS MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table NORTH AMERICA: MERCHANT SYNTHETIC HPAPI MANUFACTURERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table EUROPE: MERCHANT SYNTHETIC HPAPI MANUFACTURERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table ASIA: MERCHANT SYNTHETIC HPAPI MANUFACTURERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table MERCHANT BIOTECH HPAPI MANUFACTURERS MARKET, BY REGION, 2016–2023 (USD MILLION)
        • Table NORTH AMERICA: MERCHANT BIOTECH HPAPI MANUFACTURERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table EUROPE: MERCHANT BIOTECH HPAPI MANUFACTURERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
        • Table ASIA: MERCHANT BIOTECH HPAPI MANUFACTURERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
  • HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION
    • INTRODUCTION
      • Table HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2016–2023 (USD MILLION)
    • ONCOLOGY
      • Table HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR ONCOLOGY, BY REGION, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR ONCOLOGY, BY COUNTRY, 2016–2023 (USD MILLION)
      • Table EUROPE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR ONCOLOGY, BY COUNTRY, 2016–2023 (USD MILLION)
      • Table ASIA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR ONCOLOGY, BY COUNTRY, 2016–2023 (USD MILLION)
    • HORMONAL IMBALANCE
      • Table HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HORMONAL IMBALANCE, BY REGION, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HORMONAL IMBALANCE, BY COUNTRY, 2016–2023 (USD MILLION)
      • Table EUROPE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HORMONAL IMBALANCE, BY COUNTRY, 2016–2023 (USD MILLION)
      • Table ASIA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HORMONAL IMBALANCE, BY COUNTRY, 2016–2023 (USD MILLION)
    • GLAUCOMA
      • Table HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR GLAUCOMA, BY REGION, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR GLAUCOMA, BY COUNTRY, 2016–2023 (USD MILLION)
      • Table EUROPE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR GLAUCOMA, BY COUNTRY, 2016–2023 (USD MILLION)
      • Table ASIA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR GLAUCOMA, BY COUNTRY, 2016–2023 (USD MILLION)
    • OTHER THERAPEUTIC APPLICATIONS
      • Table HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2016–2023 (USD MILLION)
      • Table EUROPE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2016–2023 (USD MILLION)
      • Table ASIA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2016–2023 (USD MILLION)
  • HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION
    • INTRODUCTION
      • Table HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2016–2023 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2016–2023 (USD MILLION)
      • US
        • Table US: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table US: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2016–2023 (USD MILLION)
        • Table US: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table US: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2016–2023 (USD MILLION)
        • Table US: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2016–2023 (USD MILLION)
        • Table US: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table US: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION
        • Table US: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
        • Table US: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2016–2023 (USD MILLION)
      • CANADA
        • Table CANADA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table CANADA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2016–2023 (USD MILLION)
        • Table CANADA: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table CANADA: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2016–2023 (USD MILLION)
        • Table CANADA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2016–2023 (USD MILLION)
        • Table CANADA: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table CANADA: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table CANADA: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
        • Table CANADA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2016–2023 (USD MILLION)
    • EUROPE
      • Table EUROPE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
      • Table EUROPE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table EUROPE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2016–2023 (USD MILLION)
      • Table EUROPE: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table EUROPE: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2016–2023 (USD MILLION)
      • Table EUROPE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2016–2023 (USD MILLION)
      • Table EUROPE: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table EUROPE: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table EUROPE: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
      • Table EUROPE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2016–2023 (USD MILLION)
      • GERMANY
        • Table GERMANY: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table GERMANY: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2016–2023 (USD MILLION)
        • Table GERMANY: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table GERMANY: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2016–2023 (USD MILLION)
        • Table GERMANY: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2016–2023 (USD MILLION)
        • Table GERMANY: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table GERMANY: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table GERMANY: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
        • Table GERMANY: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2016–2023 (USD MILLION)
      • FRANCE
        • Table FRANCE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table FRANCE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2016–2023 (USD MILLION)
        • Table FRANCE: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table FRANCE: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2016–2023 (USD MILLION)
        • Table FRANCE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2016–2023 (USD MILLION)
        • Table FRANCE: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table FRANCE: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table FRANCE: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
        • Table FRANCE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2016–2023 (USD MILLION)
      • UK
        • Table UK: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table UK: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2016–2023 (USD MILLION)
        • Table UK: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table UK: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2016–2023 (USD MILLION)
        • Table UK: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2016–2023 (USD MILLION)
        • Table UK: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table UK: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table UK: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
        • Table UK: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2016–2023 (USD MILLION)
      • ITALY
        • Table ITALY: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table ITALY: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2016–2023 (USD MILLION)
        • Table ITALY: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table ITALY: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2016–2023 (USD MILLION)
        • Table ITALY: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2016–2023 (USD MILLION)
        • Table ITALY: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table ITALY: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table ITALY: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
        • Table ITALY: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2016–2023 (USD MILLION)
      • SPAIN
        • Table SPAIN: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table SPAIN: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2016–2023 (USD MILLION)
        • Table SPAIN: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table SPAIN: MERCHANT MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2016–2023 (USD MILLION)
        • Table SPAIN: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2016–2023 (USD MILLION)
        • Table SPAIN: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table SPAIN: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table SPAIN: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
        • Table SPAIN: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2016–2023 (USD MILLION)
      • REST OF EUROPE (ROE)
        • Table ROE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table ROE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2016–2023 (USD MILLION)
        • Table ROE: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table ROE: MERCHANT MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2016–2023 (USD MILLION)
        • Table ROE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2016–2023 (USD MILLION)
        • Table ROE: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table ROE: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table ROE: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
        • Table ROE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2016–2023 (USD MILLION)
    • ASIA
      • Table ASIA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
      • Table ASIA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table ASIA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2016–2023 (USD MILLION)
      • Table ASIA: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table ASIA: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2016–2023 (USD MILLION)
      • Table ASIA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2016–2023 (USD MILLION)
      • Table ASIA: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table ASIA: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table ASIA: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
      • Table ASIA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2016–2023 (USD MILLION)
      • JAPAN
        • Table JAPAN: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table JAPAN: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2016–2023 (USD MILLION)
        • Table JAPAN: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table JAPAN: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2016–2023 (USD MILLION)
        • Table JAPAN: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2016–2023 (USD MILLION)
        • Table JAPAN: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table JAPAN: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table JAPAN: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
        • Table JAPAN: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2016–2023 (USD MILLION)
      • CHINA
        • Table CHINA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table CHINA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2016–2023 (USD MILLION)
        • Table CHINA: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table CHINA: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2016–2023 (USD MILLION)
        • Table CHINA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2016–2023 (USD MILLION)
        • Table CHINA: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table CHINA: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table CHINA: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
        • Table CHINA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2016–2023 (USD MILLION)
      • INDIA
        • Table INDIA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table INDIA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2016–2023 (USD MILLION)
        • Table INDIA: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table INDIA: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2016–2023 (USD MILLION)
        • Table INDIA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2016–2023 (USD MILLION)
        • Table INDIA: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table INDIA: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table INDIA: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
        • Table INDIA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2016–2023 (USD MILLION)
      • REST OF ASIA (ROA)
        • Table ROA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table ROA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2016–2023 (USD MILLION)
        • Table ROA: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table ROA: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2016–2023 (USD MILLION)
        • Table ROA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2016–2023 (USD MILLION)
        • Table ROA: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table ROA: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table ROA: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
        • Table ROA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2016–2023 (USD MILLION)
    • REST OF THE WORLD (ROW)
      • Table ROW: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table ROW: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2016–2023 (USD MILLION)
      • Table ROW: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table ROW: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2016–2023 (USD MILLION)
      • Table ROW: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2016–2023 (USD MILLION)
      • Table ROW: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table ROW: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table ROW: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
      • Table ROW: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2016–2023 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • MARKET RANKING ANALYSIS
      • Table MARKET RANKING ANALYSIS, BY KEY PLAYER, 2017
    • COMPETITIVE SITUATION AND TRENDS
      • AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
        • Table AGREEMENTS, COLLABORATIONS, PARTNERSHIPS, AND ALLIANCES (2015–2018)
      • MERGERS AND ACQUISITIONS
        • Table MERGERS AND ACQUISITIONS (2015-2018)
      • EXPANSIONS
        • Table EXPANSIONS (2015–2018)
  • COMPANY PROFILES
    • PFIZER
      • BUSINESS OVERVIEW
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • NOVARTIS INTERNATIONAL AG
      • BUSINESS OVERVIEW
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • SANOFI
      • BUSINESS OVERVIEW
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • F. HOFFMANN-LA ROCHE
      • BUSINESS OVERVIEW
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BRISTOL-MYERS SQUIBB
      • BUSINESS OVERVIEW
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BOEHRINGER INGELHEIM
      • BUSINESS OVERVIEW
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • TEVA PHARMACEUTICAL INDUSTRIES
      • BUSINESS OVERVIEW
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ELI LILLY AND COMPANY
      • BUSINESS OVERVIEW
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • MERCK
      • BUSINESS OVERVIEW
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ABBVIE
      • BUSINESS OVERVIEW
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • MYLAN
      • BUSINESS OVERVIEW
      • RECENT DEVELOPMENTS
    • BAYER
      • BUSINESS OVERVIEW
  • APPENDIX
    • INSIGHTS FROM INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report